ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Cuprior 150 mg, Filmtabletten - 72
67719001 Curatis AG
Cuprior 150 mg, Filmtabletten21.01.2021
  21.01.2021
Trientine (A16AX12) 
WHO-DDD20.01.2026
07.99.72
07.99. 
B  
Yes 
IPCI
3022.28Yes
    
10 %3303.35
7680677190018Synthetika
  
Composition
trientinum 150 mg ut trientini tetrahydrochloridum, mannitolum, silica colloidalis anhydrica, glyceroli dibehenas, Überzug: poly(alcohol vinylicus), talcum, E 171, glyceroli monocaprylocapras, E 172 (flavum), natrii laurilsulfas corresp. natrium 0.057 mg, pro compresso obducto.
Packungsbestandteile
Coated tablets 
 
Active AgentDose
Trientinum150 mg
BAG: Active AgentDose
Trientinum150 mg
 
Inactive agents additional_information
(Flavum)  
E 171 color.
E 172 color.
Glyceroli Dibehenas  
Glyceroli Monocaprylocapras  
Mannitol  
Natrii Laurilsulfas  
Poly(Alcohol Vinylicus) Überzug
Pro Compresso Obducto  
Silica Colloidalis Anhydrica  
Talcum  
 
Source
Data was imported : 03.02.2021 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home